Game Changer: Merck's Stealth Keytruda-Chemo Filing Stirs NSCLC Market Dynamics

 
• By Lucie Ellis-Taitt
  
Sparrow
Early bird Merck hopes to catch the worm, files Keytruda/Chemo combo months sooner than expected • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer